STOK STOKE THERAPEUTICS INC
2026Q1 · CUSIP 86150R107 · Sector: Healthcare & Biotech
Cooling · Breadth rolling over
Holders
196
Δ holders QoQ
+12
Breadth percentile
Top 25%
Whale holders
110
Δ whales
+12
Inst. holding value
$2.3B
New positions
43
Closed positions
31
Price momentum (1Q)
-6.6%
Put / Call
4/4
Breadth history (34 quarters)
Past Lit Events & Aftermath 5 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2025Q4 | Top 16% | -6.6% | — |
| 2024Q1 | Top 13% | +6.8% | -13.5% |
| 2022Q3 | Top 12% | +1.9% | +24.4% |
| 2020Q3 | Top 15% | +31.0% | -22.0% |
| 2020Q1 | Top 19% | +3.9% | +62.8% |
Options Sentiment
Put holders
4
QoQ: +1
Call holders
4
QoQ: -2
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-2.81
EPS YoY
-442.7%
Revenue (TTM)
$0.0B
Revenue YoY
-83.2%
Net margin
—
ROE
-43.0%
Debt ratio
10.9%
FCF (TTM)
-$148M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
P/E (TTM) over time
P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden
As of 2026-03-31 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.